CLINICAL_TRIALS
trial_result
· 2020-12-23
Clinical Trial Update: Naglazyme After Allo Transplant for Maroteaux-Lamy Syndrome [NA]
Summary
A clinical trial update for Naglazyme after allo-transplant in Maroteaux-Lamy Syndrome has been terminated, with results posted in 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Maroteaux-Lamy Syndrome | NA | Status: TERMINATED | Results posted: 2020-12-23